United States · FDA National Drug Code directory

AMPICILLIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0404-9818_3ca96638-a32c-4d90-8850-c258cd5abf8d
Product NDC
0404-9818
Form
INJECTION, POWDER, FOR SOLUTION
Composition / generic term
AMPICILLIN SODIUM
Labeler
Henry Schein, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20220117
Source listing expiry
20271231

Source-listed ingredients

  • AMPICILLIN SODIUM — 2 g/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 VIAL in 1 BAG (0404-9818-99) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL · 0404-9818-99

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
AMPICILLIN — United States | Molindra Medicines